Back to results
US 2026/0272957 A1Published application
Treatment of syngap1 encephalopathy
AssigneeHarmony Biosciences Management, Inc.
InventorsTerri Sebree, John Messenheimer, Donna Gutterman
Life of this patent
Estimating the term…
Abstract
The present technology relates to methods of treating SYNGAP1 encephalopathy by transdermally administering an effective amount of cannabidiol (CBD) to the subject, wherein a SYNGAP1 symptom is treated in the subject.
Claims22
A method of treating SYNGAP1 encephalopathy, the method comprising:
- transdermally administering an effective amount of cannabidiol (CBD) to the subject, wherein a SYNGAP1 symptom is treated in the subject.
Dependencies are inferred from the claim text.